Getinge AB (publ) (STO:GETI.B)
Sweden
· Delayed Price · Currency is SEK | Market Cap | 57.52B |
| Revenue (ttm) | 35.85B |
| Net Income (ttm) | 2.05B |
| Shares Out | 272.37M |
| EPS (ttm) | 7.54 |
| PE Ratio | 28.01 |
| Forward PE | 19.37 |
| Dividend | 4.60 (2.18%) |
| Ex-Dividend Date | Apr 23, 2025 |
| Volume | 337,451 |
| Average Volume | 361,102 |
| Open | 211.00 |
| Previous Close | 210.70 |
| Day's Range | 210.00 - 211.80 |
| 52-Week Range | 166.55 - 231.60 |
| Beta | 0.94 |
| RSI | 43.46 |
| Earnings Date | Jan 27, 2026 |
About Getinge AB
Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It provides extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company offers surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardioth... [Read more]
Financial Performance
In 2024, Getinge AB's revenue was 34.76 billion, an increase of 9.21% compared to the previous year's 31.83 billion. Earnings were 1.64 billion, a decrease of -32.09%.
Financial StatementsNews
Getinge AB (GNGBY) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amid Tariff Challenges
Getinge AB (GNGBY) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amid Tariff Challenges
Q3 2025 Getinge AB Earnings Call Transcript
Q3 2025 Getinge AB Earnings Call Transcript
Getinge AB (publ) (GNGBY) Q3 2025 Earnings Call Transcript
Getinge AB (GNGBF) Reports Strong Q3 Performance with Revenue Growth
Getinge AB (GNGBF) Reports Strong Q3 Performance with Revenue Growth
Getinge AB (publ) 2025 Q3 - Results - Earnings Call Presentation
Getinge AB Non-GAAP EPS of SEK 2.42, revenue of SEK 8.23B; reaffirms FY outlook
Medical gear maker Getinge tops core profit estimates in third quarter
Swedish medical equipment maker Getinge reported third-quarter core earnings above market expectations on Tuesday, supported by price adjustments to combat a hit from U.S. tariffs and negative currenc...
Getinge AB (publ) (GNGBF) Q2 2025 Earnings Call Transcript
Getinge AB (publ) 2025 Q2 - Results - Earnings Call Presentation
The following slide deck was published by Getinge AB (publ) in conjunction with their 2025 Q2 earnings call.
Getinge AB (publ) reports Q2 results
Getinge AB (publ) (GNGBF) Q1 2025 Earnings Call Transcript
Getinge Interim Report January-March 2025: Strong sales and improved earnings - continued focus on customer value and profitability going forward
GOTHENBURG, Sweden , April 22, 2025 /PRNewswire/ -- "We are entering 2025 with healthy organic sales growth and improved adjusted operating profit despite headwinds from currency effects," says Mattia...
Getinge AB (GNGBF) Q1 Earnings Show Revenue Growth
Getinge AB (GNGBF) Q1 Earnings Show Revenue Growth
Getinge AB Non-GAAP EPS of €0.46, revenue of €520.1M; initiates FY25 outlook
Getinge AB (GNGBF) Q4 2024 Earnings Call Transcript
Getinge AB (OTCPK:GNGBF) Q4 2024 Results Conference Call January 28, 2025 4:00 AM ETCompany ParticipantsMattias Perjos - President & CEOAgneta Palmer -...
Getinge AB: Why We Think There's Confusion Of Frequency And Magnitude
We detail why we think there’s confusion of frequency and magnitude in the case of Getinge. Click here to read more.
Getinge AB (publ) reports Q3 results
Getinge AB (publ) reported Q3 adjusted earnings of SEK 2.24 per share, with organic sales and order intake growth, strong gross profit, and cash flow.
Getinge AB (publ) 2024 Q3 - Results - Earnings Call Presentation
Getinge AB (GNGBF) Q3 2024 Earnings Call Transcript
Getinge misses Q3 forecasts, weighed by quality and delivery issues
Swedish medical equipment maker Getinge missed forecasts for third-quarter profit and sales on Friday despite strong orders, hit by delivery issues and costs of solving prolonged quality problems.
Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings
GOTHENBURG, Sweden , Oct. 18, 2024 /PRNewswire/ -- "The order intake increased by 10.0%, of which organic growth was 7.4%. All regions reported a positive performance," says Mattias Perjos, President ...
Swedish firm Getinge to buy Paragonix Technologies for about $477 mln
Swedish medical-equipment maker Getinge said on Thursday it will acquire U.S.-based organ transport company Paragonix Technologies for about $477 million.
Getinge AB (GNGBF) Q2 2024 Earnings Call Transcript
Getinge AB (OTCPK:GNGBF) Q2 2024 Earnings Conference Call July 18, 2024 4:00 AM ET Company Participants Mattias Perjos - President and Chief Executive Officer Agneta Palmer - Chief Financial Officer C...
Getinge AB (GNGBF) Q1 2024 Earnings Call Transcript
Getinge AB (OTCPK:GNGBF) Q1 2024 Earnings Conference Call April 22, 2024 7:00 AM ET Company Participants Mattias Perjos - President & CEO Agneta Palmer - CFO Conference Call Participants Erik Cassel -...
Medical gear maker Getinge's Q1 core profit beats expectations
Medical equipment maker Getinge reported a smaller-than-expected drop in first-quarter core profit on Monday, as new orders offset the costs of resolving prolonged problems with its product packaging ...